Becker's Hospital Review

FDA approves Relistor to treat opioid-induced constipation

The Food and Drug Administration recently approved the tablet form of Relistor to treat opioid-induced constipation. Relistor, produced by Tarrytown, N.Y.-based Progenics Pharmaceuticals, was ...
FOX31 Denver

Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell ...

LAVAL, QC / ACCESSWIRE / March 6, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, today announced that it is supporting a Phase 2 ...
Benzinga.com

UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation III Approves Salix Request For FDA Approval Of RELISTOR sNDA

Salix Pharmaceuticals, Ltd. SLXP and Progenics Pharmaceuticals PGNX today announced that the Food and Drug Administration (FDA or Agency) has informed Salix that RELISTOR® (methylnaltrexone bromide) ...
Reuters

Wyeth, Progenics bowel drug wins EU approval

NEW YORK, July 3 (Reuters) - Wyeth and Progenics Pharmaceuticals Inc won European approval for Relistor, a drug used to treat constipation that occurs with the use of opioid painkillers, like morphine ...